Clinical Trials Logo

Filter by:
  • None
  • Page [1]
NCT ID: NCT02070211 Not yet recruiting - Clinical trials for 22q11 Deletion Syndrome

Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

Start date: June 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the present trial is to investigate the effects of omega-3 PUFAs in individuals aged 12-26 years with 22q11DS at ultra-high risk for developing a first episode of psychosis.

NCT ID: NCT01812551 Completed - Cystic Fibrosis Clinical Trials

Treatment of Low Bone Density in Cystic Fibrosis.

OSCYF
Start date: October 2002
Phase: Phase 3
Study type: Interventional

Cystic fibrosis (CF) -- an autosomal recessive genetic disease affecting about 60,000 individuals worldwide, including about 3,800 in Italy -- is often associated with low bone mineral mass. The current aggressive therapies have ensured a much longer survival of CF patients but this has led to a higher frequency of osteoporosis and bone fractures, a serious problem which not only affects quality of life, but also hinders further therapeutic measures. The aim of this study, conducted on a large group of children, adolescents and young adults with CF, has been the evaluation of bone mass changes after 1 year of a simple treatment with RDA-adjusted dietary calcium plus 25-OH vitamin D supplementation, and the feasibility and efficacy of alendronate treatment (for another year) in patients not responding to calcium + 25-OH vitamin D alone.